NCT01783600View on ClinicalTrials.gov

NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Peripheral Arterial Disease

Interventions

DEVICE

NanoCross .014 balloon catheter

Trial Locations (4)

2820

Imelda Hospital, Bonheiden

3300

RZ Heilig Hart Tienen, Tienen

9200

AZ Sint-Blasius, Dendermonde

9300

OLV Aalst, Alast

All Listed Sponsors

lead

Flanders Medical Research Program

NETWORK

NCT01783600 - NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions | Biotech Hunter | Biotech Hunter